Therapeutische gebieden

Nieuwe typen griepvaccins

Nieuwe typen griepvaccins kunnen de effectiviteit van de griepprik verbeteren. De Gezondheidsraad bracht hierover eind 2024 advies uit. Welke punten hebben hierin een rol gespeeld?

Type 2 in PN herkennen

Type 2 inflammatie in Prurigo Nodularis (PN)

Atopic Dermatitis Control Tool (ADCT)

GO-Doctor: Play, Experience, Learn

Lukt het jou om deze klinische casussen op tijd te diagnosticeren?

Switch naar Toujeo

Download hier de verschillende switch materialen.

DERM 360°: Advancing Treatments for Chronic Itch and Pain in AD and PN

DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice

3rd of December 2024

DERM 360°

Clinical challenges to achieve long-term disease control within treatment of moderate to severe AD.

Addressing Bone Disease in Lysosomal storage diseases

The Deliver-G study

DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†¹

Mucus plugs in Asthma, and the influence of Type 2 inflammation